Pharmaco - Press Releases

Date	Title	Company
01-Nov-2022	Procurement and supply chain brought together under the new Chief Operations Officer	Zur Rose Group AG
31-Oct-2022	Biophytis publishes its key financial figures as at 30 June 2022, announces a restatement of the financial statements published as of December 31st, 2021 and provides an update on the oper	Biophytis
31-Oct-2022	Aptar Pharma Completes First Phase of Global Expansion Program to Meet Growing Customer Capacity Needs for Injectable Drug Delivery	Aptar Pharma
31-Oct-2022	SynBiotic SE completes successfully capital increase and places all new shares	SynBiotic SE
31-Oct-2022	European Medicines Agency Validates Santhera’s Marketing Authorization Application for Vamorolone in Duchenne Muscular Dystrophy	Santhera Pharmaceuticals
31-Oct-2022	Santhera Announces Half-Year 2022 Financial Results and Provides Corporate Update	Santhera Pharmaceuticals
31-Oct-2022	Preclinical Data Demonstrates SonoTran® Increased Delivery and Efficacy of ADCT-601 in Human Renal Cancer Model	B3C newswire
31-Oct-2022	DEFENCE TO APPLY ITS PROPRIATRY ACCUMTM TECHNOLOGY IN THE DESIGN OF MESSENGER RNA ANTI-CANCER VACCINES	Defence Therapeutics Inc.
30-Oct-2022	Challenging macroeconomic environment impact Fresenius Medical Care and Fresenius Group earnings in FY/22; Fresenius SE & Co. KGaA Group guidance revised	Fresenius SE & Co. KGaA
30-Oct-2022	Fresenius Medical Care AG & Co. KGaA revises financial outlook for full year 2022	Fresenius Medical Care AG & Co. KGaA
30-Oct-2022	Fresenius Medical Care AG & Co. KGaA extends net income target range for financial year 2022	Fresenius Medical Care AG & Co. KGaA
30-Oct-2022	IGEA Pharma N.V.: Igea discloses its 2022 Half-Year Financial Report	IGEA Pharma N.V.
28-Oct-2022	European Medicines Agency validates ViiV Healthcare’s marketing authorisation application for cabotegravir long-acting injectable for HIV Prevention	ViiV Healthcare
28-Oct-2022	Inizio commits to helping limit the impact of climate change and achieving SBTi Net-Zero Standard	Inizio
28-Oct-2022	AEVIS VICTORIA SA – AEVS.SW – Visana enters into the share capital of Hôpital du Jura Bernois, a subsidiary of Swiss Medical Network	AEVIS VICTORIA SA
28-Oct-2022	Evotec, CDP Venture Capital and Angelini Ventures launch translational partnership 'Extend' with leading Italian academic Institutions	Evotec SE
28-Oct-2022	New NoriZite™ Nasal Spray launches in the UK	Sciad Newswire
28-Oct-2022	Formycon reports final figures for the first half of 2022	Formycon AG
27-Oct-2022	MorphoSys Presents Preliminary Results from Phase 1/2 Study of Tulmimetostat (CPI-0209) Supporting Its Potential Application in a Broad Array of Advanced Tumors	MorphoSys AG
27-Oct-2022	MagForce AG Decides to Delist its Shares	MagForce AG